DISCOUNT-ZERTIFIKAT - MEDIGENE Share Price

Certificat

DE000DQ228Q1

Real-time Boerse Frankfurt Warrants 10:04:45 17/06/2024 pm IST
1.11 EUR -1.77% Intraday chart for DISCOUNT-ZERTIFIKAT - MEDIGENE
Current month+5.56%
1 month-9.52%
Date Price Change
17/24/17 1.11 -1.77%
14/24/14 1.14 +0.88%
13/24/13 1.13 -0.88%
12/24/12 1.14 +0.88%
11/24/11 1.13 -1.74%

Real-time Boerse Frankfurt Warrants

Last update June 17, 2024 at 10:04 pm IST

More quotes

Static data

Product typeCertificati Discount
Buy / SellCALL
Underlying MEDIGENE AG
Issuer DZ BANK
WKN DQ228Q
ISINDE000DQ228Q1
Date issued 29/04/2024
Maturity 21/03/2025 (277 Days)
Parity 1 : 1
Emission price 1.31
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.33
Lowest since issue 1.05
Spread 0.1
Spread %8.26%

Company Profile

Medigene AG is a Germany-based biotechnology company that develops treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. The Company focuses on the development of personalized T cell-based immunotherapies. It develops three platforms: T-cell receptor (TCR)-modified T cells for adoptive T-cell therapy as treatments for patients with tumor burdens; Dendritic cell (DC) vaccines for the treatment of low tumor burdens, such as minimal residual disease or for use in combination therapies, and T-cell-specific monoclonal antibodies (TABS) to identify T cells based on their T-cell receptors. The Company operates offices in Martinsried in Germany, as well as in Washington DC and San Diego in the United States.
Sector
-
More about the company

Ratings for Medigene AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Medigene AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.275 EUR
Average target price
2.675 EUR
Spread / Average Target
+109.80%
Consensus